Feline Asthma (Allergic Bronchitis)

Feline asthma, also referred to as allergic bronchitis or feline bronchial disease, is one of the most common inflammatory lower airway diseases affecting domestic cats. It is broadly characterized by reversible bronchoconstriction, airway hyperresponsiveness, and eosinophilic inflammation driven by an underlying hypersensitivity response [1]. The disease is believed to be primarily allergic in etiology, involving sensitization to inhaled aeroallergens that trigger a cascade of immune-mediated inflammation in the lower respiratory tract [2]. Distinguishing true allergic asthma from non-allergic chronic bronchitis in cats remains a diagnostic challenge, as both conditions share overlapping clinical presentations and have historically been grouped together in the veterinary literature [1].

Allergic Basis

Feline asthma is considered to be of allergic origin in the majority of cases [1]. Sensitization typically occurs through repeated inhalation of environmental aeroallergens, triggering an adaptive immune response dominated by T-helper 2 (Th2) lymphocytes. Common suspected aeroallergens include house dust mites, mold spores, pollen, cigarette smoke, cat litter dust, perfumes, and other airborne particulates [2]. Studies using intradermal testing (IDT) and serum allergen-specific IgE (SAT) have demonstrated positive allergen reactions in cats with clinical signs of feline bronchial disease, supporting an allergic mechanism, though positive rates and allergen profiles vary between individual cats [2][5].

Immunological Cascade

Upon re-exposure to a sensitizing allergen, mast cells and basophils coated with allergen-specific IgE undergo degranulation, releasing histamine, leukotrienes, and prostaglandins. This early-phase response causes rapid bronchoconstriction. A subsequent late-phase response involves eosinophil recruitment into the airways, driven by cytokines such as IL-5 and eotaxin. Eosinophil-derived toxic granule proteins (major basic protein, eosinophil peroxidase) cause direct epithelial damage, mucus hypersecretion, and airway remodeling over time [1]. Serum IgE responses to aeroallergens have been documented in cats with naturally occurring airway eosinophilia, further supporting the role of atopic mechanisms [4].

Airway Remodeling

In chronic or inadequately managed cases, persistent inflammation leads to irreversible structural changes, including subepithelial fibrosis, smooth muscle hypertrophy, goblet cell metaplasia, and mucus plugging. These changes progressively reduce airway lumen diameter, contributing to fixed (rather than fully reversible) airflow limitation [1].

Differentiating Asthma from Chronic Bronchitis

While asthma is characterized by eosinophilic inflammation and a presumed allergic etiology, chronic bronchitis in cats is associated with neutrophilic or mixed inflammation and an unknown etiology [2]. Accurate differentiation is clinically important because the two conditions may require different management strategies, though overlap exists and distinction is not always possible without advanced diagnostics [1][2].

History and Physical Examination

A thorough history focusing on the frequency and character of coughing episodes, potential allergen exposures (e.g., dusty litter, carpeting, smoking household members), and response to prior treatments is essential. Physical examination may reveal increased expiratory effort, expiratory wheeze on thoracic auscultation, and occasionally crackles. During acute episodes, severe dyspnea and cyanosis may be present.

Thoracic Radiography

Thoracic radiographs are a primary diagnostic tool and commonly demonstrate a bronchial pattern (prominent "doughnuts" and "tramlines"), with or without hyperinflation from air trapping and a flattened diaphragm. In acute severe cases, atelectasis — most commonly of the right middle lung lobe — may be observed due to mucus plugging [1].

Bronchoalveolar Lavage (BAL) and Cytology

Cytological evaluation of BAL fluid is considered one of the most informative diagnostic steps. A predominance of eosinophils (>17% in most reference ranges) supports a diagnosis of allergic/eosinophilic airway disease [4]. BAL cytology also allows differentiation from chronic bronchitis (neutrophilic predominance) and aids in ruling out infectious causes [1].

Pulmonary Function Testing and Bronchoprovocation

In research and specialty settings, barometric whole-body plethysmography (BWBP) and oscillometry can objectively assess airway hyperresponsiveness and the degree of bronchoconstriction. Methacholine bronchoprovocation testing can confirm airway hyperreactivity [1].

Allergy Testing

• ·Intradermal testing (IDT): Considered the gold standard for identifying specific allergen sensitivities. Studies have shown positive reactions in cats with feline asthma (FA), with different allergen profiles compared to cats with chronic bronchitis [2].
• ·Serum allergen-specific IgE (SAT): A less invasive alternative; studies have demonstrated elevated IgE responses to various aeroallergens in cats with airway eosinophilia [4][5]. However, the correlation between positive allergy tests and clinically relevant allergens requires careful interpretation [2][4].

Laboratory Findings

Routine bloodwork may support the diagnosis but is rarely definitive:

• ·Complete blood count (CBC): Peripheral eosinophilia may be present but is neither sensitive nor specific; many asthmatic cats have normal WBC differential counts
• ·HCT (hematocrit): Generally normal unless concurrent disease is present
• ·Serum chemistry panel (ALT, BUN, CREA, GLOB, ALB): Typically within normal limits; used primarily to rule out concurrent systemic illness and to screen prior to corticosteroid therapy
• ·Fecal flotation and thoracic radiographs should be performed to exclude parasitic respiratory disease (e.g., Aelurostrongylus abstrusus, Toxocara cati larval migration)

Differential Diagnoses

Key differentials include chronic bronchitis, lungworm infection, cardiac disease (left-sided heart failure causing pulmonary edema), pulmonary neoplasia, pleural effusion, and pneumonia. Thorough diagnostic workup is essential before committing to long-term immunosuppressive therapy.

Emergency Management of Acute Attacks

Acute asthmatic crises are medical emergencies. Immediate priorities include:

• ·Supplemental oxygen therapy (oxygen cage or flow-by oxygen)
• ·Bronchodilators: Short-acting beta-2 agonists such as albuterol (salbutamol) via metered-dose inhaler (MDI) with a feline aerosol chamber (e.g., AeroKat) are the first-line rescue therapy. Injectable terbutaline (0.01 mg/kg SC or IM) is an alternative when inhalation is not feasible
• ·Glucocorticoids: Rapid-acting systemic corticosteroids (e.g., dexamethasone sodium phosphate IV) are administered to reduce acute airway inflammation
• ·Minimize stress and handling until the animal is stabilized

Long-Term Anti-Inflammatory Therapy

Glucocorticoids remain the cornerstone of chronic asthma management in cats [1]:

• ·Prednisolone (oral): Typically initiated at immunosuppressive doses (1–2 mg/kg/day) and tapered to the lowest effective dose over weeks to months
• ·Fluticasone propionate (inhaled): Delivered via MDI and AeroKat chamber; preferred for long-term management to reduce systemic side effects, especially in cats requiring sustained corticosteroid therapy. Inhaled corticosteroids take several weeks to achieve full effect and are not suitable as sole therapy for acute episodes [1]
• ·Depot methylprednisolone injections (e.g., methylprednisolone acetate) may be used in cats where oral or inhaled administration is not feasible, though they carry higher risks of iatrogenic diabetes mellitus and adrenal suppression

Bronchodilator Therapy

• ·Inhaled albuterol (salbutamol): Used as rescue therapy for acute bronchospasm; regular scheduled use is not recommended as sole therapy without concurrent anti-inflammatory treatment [1]
• ·Theophylline (sustained-release oral): An older bronchodilator with mild anti-inflammatory properties; used as adjunctive therapy in some cases
• ·Terbutaline (oral or injectable): Alternative bronchodilator for cats unable to use inhalers

Allergen Avoidance and Environmental Management

Identifying and eliminating trigger allergens is an important component of long-term management [2][5]. Recommended measures include:

• ·Switching to low-dust, unscented cat litter
• ·Using HEPA air purifiers
• ·Eliminating tobacco smoke, aerosol sprays, scented candles, and strong cleaning products from the environment
• ·Frequent vacuuming and washing of bedding to reduce dust mite burden

Allergen-Specific Immunotherapy (ASIT)

For cats with confirmed aeroallergen sensitization, allergen-specific immunotherapy (hyposensitization) may be considered [2][5]. While data in cats is limited compared to humans and dogs, ASIT aims to induce immunological tolerance and reduce clinical signs over time. It requires accurate allergen identification via IDT or SAT testing [2].

Acupuncture (Complementary Therapy)

Traditional Chinese Medicine-based acupuncture has been described as a complementary approach that may enhance the treatment of chronic allergic bronchitis and asthma in cats, potentially allowing reduction in conventional medication doses in some cases [3]. It is not a replacement for standard medical therapy but may be considered as an adjunct in suitable patients.

Monitoring and Follow-Up

Regular reassessment including thoracic radiography, owner-reported symptom diaries, and periodic CBC/chemistry panels is recommended to monitor disease control, assess for treatment complications (particularly hyperglycemia, weight gain, and susceptibility to infection with chronic steroid use), and guide dose adjustments.

General Prognosis

The overall prognosis for cats with feline asthma is considered good to guarded with appropriate diagnosis and ongoing management. Most cats can achieve satisfactory quality of life with a combination of long-term anti-inflammatory therapy, bronchodilator rescue medications, and allergen avoidance strategies [1].

Factors Affecting Prognosis

• ·Disease severity at diagnosis: Cats with mild-to-moderate disease that respond well to initial corticosteroid therapy generally carry a favorable long-term outlook
• ·Frequency and severity of acute attacks: Cats prone to recurrent severe asthmatic crises (status asthmaticus) carry a more guarded prognosis due to the risk of fatal respiratory failure during an uncontrolled episode
• ·Presence of airway remodeling: Chronic, irreversible structural changes to the airway reduce the likelihood of achieving full clinical remission and may result in progressive deterioration despite treatment [1]
• ·Owner compliance: Because feline asthma requires lifelong management, owner adherence to medication schedules, inhaler technique, and environmental modifications significantly influences long-term outcomes

Mortality Considerations

Feline asthma can be directly life-threatening during severe acute episodes due to acute bronchoconstriction and hypoxemia. Without prompt emergency intervention, acute asthmatic crises may be fatal. Specific peer-reviewed mortality rate statistics for the overall population of asthmatic cats are not clearly established in the references cited above; the disease is better characterized by its chronicity and management-dependent outcome than by a single survival statistic. The literature emphasizes that with improved diagnostics and targeted therapeutics, outcomes are expected to continue improving [1].

Long-Term Outlook

Many cats require lifelong medication. While true remission is uncommon, satisfactory disease control—defined as infrequent acute episodes, preserved activity levels, and acceptable quality of life—is achievable in the majority of well-managed cases. Cats that develop significant airway remodeling or secondary complications (e.g., cor pulmonale from chronic hypoxia) have a more guarded to poor prognosis [1].

Primary Prevention

There is currently no vaccine available for feline asthma. Since the disease is driven by allergen sensitization and immune-mediated inflammation, true primary prevention is difficult to guarantee; however, reducing early and sustained exposure to known aeroallergens may lower the risk of sensitization in genetically predisposed individuals [1][2].

Environmental Control Measures

• ·Use low-dust, fragrance-free clumping litters; avoid clay or silica dust-generating products
• ·Avoid cigarette, cigar, or e-cigarette smoke in the home environment
• ·Minimize use of aerosol sprays, air fresheners, scented candles, and strong household chemicals around cats
• ·Use HEPA filtration vacuum cleaners and air purifiers to reduce airborne allergen load
• ·Wash cat bedding regularly in hot water to reduce dust mite antigen levels
• ·Avoid heavily carpeted environments if possible, as carpets harbor dust mites and mold spores [2][5]

Early Detection and Monitoring

Owners with cats showing early or intermittent coughing should seek prompt veterinary evaluation rather than attributing signs to hairballs. Early diagnosis and institution of therapy before significant airway remodeling occurs is associated with a better long-term outcome [1].

Allergen-Specific Immunotherapy as Secondary Prevention

In cats with confirmed allergen sensitivities, allergen-specific immunotherapy may serve a secondary preventive role by modulating the immune response and potentially reducing disease progression over time [2][5].

Avoiding Iatrogenic Complications

Long-term corticosteroid use, while necessary for disease control, carries risks of iatrogenic diabetes mellitus, obesity, and increased infection susceptibility. Transitioning stable cats to the lowest effective dose of inhaled corticosteroids when feasible is recommended to reduce systemic side effects and improve long-term health [1].